Cargando…
Author Correction: Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
Autores principales: | Han, Donghoon, Kang, Si-Hyuck, Yoon, Chang-Hwan, Youn, Tae-Jin, Chae, In-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318006/ https://www.ncbi.nlm.nih.gov/pubmed/37400493 http://dx.doi.org/10.1038/s41598-023-37877-5 |
Ejemplares similares
-
Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
por: Han, Donghoon, et al.
Publicado: (2022) -
Author Correction: Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size
por: Valls-Lacalle, Laura, et al.
Publicado: (2019) -
Author Correction: Laboratory dielectric measurements to evaluate the conductivity change in the presence of chelating agent with different brines
por: Alarifi, Sulaiman A., et al.
Publicado: (2023) -
Attenuating ischemia/reperfusion injury in rat cardiac transplantation by intracoronary infusion with siRNA cocktail solution
por: Yang, Bo, et al.
Publicado: (2020) -
Author Correction: Catestatin attenuates endoplasmic reticulum induced cell apoptosis by activation type 2 muscarinic acetylcholine receptor in cardiac ischemia/reperfusion
por: Liao, Feng, et al.
Publicado: (2020)